Apollo Hospitals Enterprise Share Price
Sector: Healthcare Facilities
7065.20 +63.00 (0.90%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7003.00
Today’s High
7088.85
52 Week Low
5690.80
52 Week High
7545.10
7073.50 +68.00 (0.97%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
7000.00
Today’s High
7092.00
52 Week Low
5693.20
52 Week High
7545.35
Key Metrics
- Market Cap (In Cr) 101586.74
- Beta 0.75
- Div. Yield (%) 0.27
- P/B 14.66
- TTM P/E 80.08
- Sector P/E 22.83
- Open Price 7007.05
- Prev Close 7002.2
Apollo Hospitals Enterprise Analysis
Price Analysis
-
1 Week4.71%
-
3 Months4.18%
-
6 Month1.2%
-
YTD-3.05%
-
1 Year11.66%
Risk Meter
- 24% Low risk
- 24% Moderate risk
- 24% Balanced Risk
- 24% High risk
- 24% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 9
- 9
- 9
- 6
- Buy
- 12
- 12
- 12
- 13
- Hold
- 2
- 2
- 2
- 2
- Sell
- 1
- 1
- 1
- 3
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 24
- 24
- 24
- 24
Apollo Hospitals Enterprise News
Prashanth Tapse of Mehta Equities suggests these 3 stocks to buy in short term
3 min read . 04 Apr 2025Stocks to watch: RIL, NCC, Dr Reddy's, M&M among shares in focus today
2 min read . 24 Mar 2025Apollo Hospitals Enterprise Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 19059.2
- Selling/ General/ Admin Expenses Total
- 6833.3
- Depreciation/ Amortization
- 686.4
- Other Operating Expenses Total
- 24.1
- Total Operating Expense
- 17348
- Operating Income
- 1711.2
- Net Income Before Taxes
- 1362.5
- Net Income
- 898.6
- Diluted Normalized EPS
- 62.58
- Period
- 2024
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023
- Total Revenue
- 16612.5
- Selling/ General/ Admin Expenses Total
- 5939.1
- Depreciation/ Amortization
- 614.8
- Other Operating Expenses Total
- 31.4
- Total Operating Expense
- 15160.2
- Operating Income
- 1452.3
- Net Income Before Taxes
- 1143.7
- Net Income
- 819.1
- Diluted Normalized EPS
- 57.78
- Period
- 2023
- Total Assets
- 14427.8
- Total Liabilities
- 8230.4
- Total Equity
- 6197.4
- Tangible Book Valueper Share Common Eq
- 355.09
- Period
- 2023
- Cashfrom Operating Activities
- 1390.5
- Cashfrom Investing Activities
- -870.6
- Cashfrom Financing Activities
- -633
- Net Changein Cash
- -113.1
- Period
- 2022
- Total Revenue
- 14662.6
- Selling/ General/ Admin Expenses Total
- 4880.7
- Depreciation/ Amortization
- 600.1
- Other Operating Expenses Total
- 17.5
- Total Operating Expense
- 12778.3
- Operating Income
- 1884.3
- Net Income Before Taxes
- 1578.1
- Net Income
- 1055.6
- Diluted Normalized EPS
- 59.34
- Period
- 2022
- Total Assets
- 13269.3
- Total Liabilities
- 7646
- Total Equity
- 5623.3
- Tangible Book Valueper Share Common Eq
- 318.22
- Period
- 2022
- Cashfrom Operating Activities
- 1796.6
- Cashfrom Investing Activities
- -847.2
- Cashfrom Financing Activities
- -791.6
- Net Changein Cash
- 157.8
- Period
- 2021
- Total Revenue
- 10560
- Selling/ General/ Admin Expenses Total
- 3652.2
- Depreciation/ Amortization
- 572.5
- Other Operating Expenses Total
- 71.7
- Total Operating Expense
- 9920.6
- Operating Income
- 639.4
- Net Income Before Taxes
- 220.7
- Net Income
- 150.4
- Diluted Normalized EPS
- 8.2
- Period
- 2021
- Total Assets
- 11416.7
- Total Liabilities
- 6814.2
- Total Equity
- 4602.5
- Tangible Book Valueper Share Common Eq
- 288.02
- Period
- 2021
- Cashfrom Operating Activities
- 1256.9
- Cashfrom Investing Activities
- -872.3
- Cashfrom Financing Activities
- -340.1
- Net Changein Cash
- 44.5
- Period
- 2020
- Total Revenue
- 11246.8
- Selling/ General/ Admin Expenses Total
- 4112.3
- Depreciation/ Amortization
- 619.1
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 10072.1
- Operating Income
- 1174.7
- Net Income Before Taxes
- 660
- Net Income
- 454.8
- Diluted Normalized EPS
- 23.48
- Period
- 2020
- Total Assets
- 11338.4
- Total Liabilities
- 7999.3
- Total Equity
- 3339.1
- Tangible Book Valueper Share Common Eq
- 211.19
- Period
- 2020
- Cashfrom Operating Activities
- 1292.8
- Cashfrom Investing Activities
- -288.8
- Cashfrom Financing Activities
- -909.5
- Net Changein Cash
- 94.5
- Period
- 2019
- Total Revenue
- 9617.44
- Selling/ General/ Admin Expenses Total
- 3831.59
- Depreciation/ Amortization
- 394.91
- Other Operating Expenses Total
- 52.06
- Total Operating Expense
- 8940.04
- Operating Income
- 677.4
- Net Income Before Taxes
- 373.54
- Net Income
- 236.05
- Diluted Normalized EPS
- 17.02
- Period
- 2019
- Total Assets
- 9183.07
- Total Liabilities
- 5849.6
- Total Equity
- 3333.47
- Tangible Book Valueper Share Common Eq
- 212.2
- Period
- 2019
- Cashfrom Operating Activities
- 904.95
- Cashfrom Investing Activities
- -710.56
- Cashfrom Financing Activities
- -214.51
- Net Changein Cash
- -20.12
- Period
- 2018
- Total Revenue
- 8243.47
- Selling/ General/ Admin Expenses Total
- 3364.7
- Depreciation/ Amortization
- 358.41
- Other Operating Expenses Total
- 42.33
- Total Operating Expense
- 7798.72
- Operating Income
- 444.75
- Net Income Before Taxes
- 171.46
- Net Income
- 117.42
- Diluted Normalized EPS
- 8.81
- Period
- 2018
- Total Assets
- 8612.83
- Total Liabilities
- 5361.32
- Total Equity
- 3251.51
- Tangible Book Valueper Share Common Eq
- 205.88
- Period
- 2018
- Cashfrom Operating Activities
- 536.96
- Cashfrom Investing Activities
- -404.91
- Cashfrom Financing Activities
- -108.5
- Net Changein Cash
- 23.55
- Period
- 2024-12-31
- Total Revenue
- 5526.9
- Selling/ General/ Admin Expenses Total
- 686.4
- Depreciation/ Amortization
- 184.6
- Other Operating Expenses Total
- 1178.3
- Total Operating Expense
- 4950
- Operating Income
- 576.9
- Net Income Before Taxes
- 530.9
- Net Income
- 372.3
- Diluted Normalized EPS
- 25.89
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 5589.3
- Selling/ General/ Admin Expenses Total
- 700.1
- Depreciation/ Amortization
- 184.5
- Other Operating Expenses Total
- 1216
- Total Operating Expense
- 4958.3
- Operating Income
- 631
- Net Income Before Taxes
- 551.7
- Net Income
- 378.8
- Diluted Normalized EPS
- 26.34
- Period
- 2024-09-30
- Total Assets
- 19547.9
- Total Liabilities
- 12046.8
- Total Equity
- 7501.1
- Tangible Book Valueper Share Common Eq
- 441.33
- Period
- 2024-09-30
- Period
- 2024-06-30
- Total Revenue
- 5085.6
- Selling/ General/ Admin Expenses Total
- 658.1
- Depreciation/ Amortization
- 177.4
- Other Operating Expenses Total
- 1129.4
- Total Operating Expense
- 4587.9
- Operating Income
- 497.7
- Net Income Before Taxes
- 418.5
- Net Income
- 305.2
- Diluted Normalized EPS
- 21.23
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 4943.9
- Selling/ General/ Admin Expenses Total
- 644.9
- Depreciation/ Amortization
- 189.7
- Other Operating Expenses Total
- 1112.8
- Total Operating Expense
- 4493.1
- Operating Income
- 450.8
- Net Income Before Taxes
- 359.6
- Net Income
- 253.8
- Diluted Normalized EPS
- 17.66
- Period
- 2024-03-31
- Total Assets
- 16753.1
- Total Liabilities
- 9817.7
- Total Equity
- 6935.4
- Tangible Book Valueper Share Common Eq
- 402.5
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1920.3
- Cashfrom Investing Activities
- -1537.2
- Cashfrom Financing Activities
- -311.1
- Net Changein Cash
- 72
- Period
- 2023-12-31
- Total Revenue
- 4850.6
- Selling/ General/ Admin Expenses Total
- 612.9
- Depreciation/ Amortization
- 167
- Other Operating Expenses Total
- 1090.9
- Total Operating Expense
- 4403.9
- Operating Income
- 446.7
- Net Income Before Taxes
- 361.9
- Net Income
- 245.3
- Diluted Normalized EPS
- 17.06
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 4846.9
- Selling/ General/ Admin Expenses Total
- 644.1
- Depreciation/ Amortization
- 163.4
- Other Operating Expenses Total
- 1116.8
- Total Operating Expense
- 4380.9
- Operating Income
- 466
- Net Income Before Taxes
- 376.9
- Net Income
- 232.9
- Diluted Normalized EPS
- 16.11
- Period
- 2023-09-30
- Total Assets
- 15560.9
- Total Liabilities
- 9052.3
- Total Equity
- 6508.6
- Tangible Book Valueper Share Common Eq
- 374.88
- Period
- 2023-09-30
- Period
- 2023-06-30
- Total Revenue
- 4417.8
- Selling/ General/ Admin Expenses Total
- 591.8
- Depreciation/ Amortization
- 166.9
- Other Operating Expenses Total
- 1048.8
- Total Operating Expense
- 4075.7
- Operating Income
- 342.1
- Net Income Before Taxes
- 270
- Net Income
- 166.6
- Diluted Normalized EPS
- 11.59
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 4302.25
- Selling/ General/ Admin Expenses Total
- 590.77
- Depreciation/ Amortization
- 159.22
- Other Operating Expenses Total
- 989.08
- Total Operating Expense
- 3973.33
- Operating Income
- 328.92
- Net Income Before Taxes
- 296.53
- Net Income
- 144.55
- Diluted Normalized EPS
- 10.06
- Period
- 2023-03-31
- Total Assets
- 14427.8
- Total Liabilities
- 8230.4
- Total Equity
- 6197.4
- Tangible Book Valueper Share Common Eq
- 355.09
- Period
- 2023-03-31
- Period
- 2022-12-31
- Total Revenue
- 4263.58
- Selling/ General/ Admin Expenses Total
- 564.77
- Depreciation/ Amortization
- 153.39
- Other Operating Expenses Total
- 977.4
- Total Operating Expense
- 3911.62
- Operating Income
- 351.96
- Net Income Before Taxes
- 265.82
- Net Income
- 153.46
- Diluted Normalized EPS
- 10.67
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Apollo Hospitals Enterprise Technical
Moving Average
SMA
- 5 Day6916.73
- 10 Day6813.75
- 20 Day6670.33
- 50 Day6497.17
- 100 Day6788.87
- 300 Day6780.61
Apollo Hospitals Enterprise Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Max Healthcare Institute
- 1084.8
- 7.8
- 0.72
- 1227.5
- 743
- 105457.97
- Apollo Hospitals Enterprise
- 7065.2
- 63
- 0.9
- 7545.1
- 5690.8
- 101586.74
- Fortis Healthcare
- 661.7
- 12.25
- 1.89
- 744
- 406.35
- 49955.58
- Narayana Hrudayalaya
- 1854.95
- 61.85
- 3.45
- 1861
- 1087.8
- 37907.91
- Global Health
- 1268.15
- -29.85
- -2.3
- 1510.1
- 936.05
- 34060.91
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Max Healthcare Institute
- 100.08
- 12.53
- 10.89
- 15.02
- Apollo Hospitals Enterprise
- 113.04
- 14.66
- 13.57
- 4.82
- Fortis Healthcare
- 85.86
- 6.55
- 5.07
- 7.63
- Narayana Hrudayalaya
- 47.45
- 13.14
- 23.44
- 9.72
- Global Health
- 71.38
- 11.73
- -
- -
Apollo Hospitals Enterprise Shareholding
Shareholding Pattern
*Promoter pledging: 3.95%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 10-Feb-25
- Quarterly Results & Interim Dividend
- 06-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 03-Aug-24
- ESOP
- 30-May-24
- Audited Results & Final Dividend
- 08-Feb-24
- Quarterly Results & Interim Dividend
- 09-Nov-23
- Quarterly Results
- 11-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 30-Aug-24
- 30-May-24
- AGM
- 19-Aug-24
- 15-Jul-24
- POM
- 30-Aug-23
- 03-Aug-23
- AGM
- 25-Aug-22
- 25-May-22
- AGM
- 25-Aug-22
- 18-Jul-22
- AGM
- 31-Aug-21
- 22-Jul-21
- AGM
- 16-Aug-21
- 13-Jul-21
- POM
- 04-May-21
- 06-Apr-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 10-Feb-25
- 15-Feb-25
- 14-Feb-25
- 9
- 30-May-24
- 17-Aug-24
- 16-Aug-24
- 10
- 08-Feb-24
- 20-Feb-24
- 20-Feb-24
- 6
- 30-May-23
- 19-Aug-23
- 18-Aug-23
- 9
- 14-Feb-23
- 24-Feb-23
- 24-Feb-23
- 6
- 25-May-22
- -
- 18-Aug-22
- 11.75
- 23-Jun-21
- -
- 18-Aug-21
- 3


